Author: Vikas Kumar
17 January 2023
Microfluidics for cell biology signifies a mini cell culture system where a single cell or a few cells are seeded into a device with input and output channels. Microfluidics is gaining traction in point-of-care (POC) diagnostics as they are associated with several advantages that facilitate the development of new POC diagnostics. Such advantages are gradually being used to facilitate POC devices for the diagnosis and detection of various diseases, ranging from cancer to infectious diseases.
The Microfluidics Market is expected to grow at a steady rate of around 18.7% during the forecast period (2022-2028) owing to the rapid, accurate findings from point-of-care tests that help with the detection and follow-up of acute infections or chronic diseases. POCT entails screens and tests conducted at or close to the point of care that yield results that are actionable in a matter of minutes.
Request for a sample of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=31384
Based on product type, the microfluidics market is segmented into microfluidic-based devices and microfluidic components. The microfluidic components are further segmented into microfluidic chips, micro pumps, microneedles, and others. Among these, microfluidic-based devices accounted for a significant market share in 2020. As the penetration of microfluidic devices in various fields of research and diagnostics increases, advanced technologies are being adopted by industry players to gain potential market share. Several companies are conducting clinical trials. For instance, in January 2022, BIOLASE, Inc., and EdgeEndo received FDA 510(k) clearance for the EdgePRO system, intended for effective disinfection and cleaning alternative within root canal processes.
On the basis of application, the microfluidics market is divided into drug delivery, point-of-care diagnostics, biotechnology research and pharmaceutical, clinical diagnostics, and others. Among these, point-of-care diagnostics accounted for the largest share of the microfluidics market in 2020. This is mainly due to the rising incidence of targeted diseases and growing demand for Point-of-care testing. In addition, the growing private investments and venture funding for the development of new products are supporting the demand for PoC diagnostics.
For a detailed analysis of the Global Microfluidics Market browse through– https://univdatos.com/report/microfluidics-market/
For a better understanding of the market adoption of the Microfluidics industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America dominated the microfluidics market with a significant share in 2020. This is mainly due to the presence of established market participants in the area, the development of cutting-edge technologies, an increase in the number of studies chosen to better sample optimization, and the sizeable demand for POC diagnostics. Additionally, the active involvement of research institutes in the creation of novel microfluidic devices is anticipated to maintain the region’s dominance in the next years.
Some of the major players operating in the market include Illumina Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Abbott Laboratories, Standard BioTools, Qiagen NV.
Global Microfluidics Market Segmentation
Market Insight, by Product Type
• Microfluidic-Based Devices
• Microfluidic Componentso Microfluidic Chipso Micro Pumpso Microneedleso Others Microfluidics
Market Insight, by Application
Market Insight, by Material
• Polymer
• Silicone• Glass• PDMS• Others
Market Insight, by Region
Top Company Profiles
Get a call back
